|
Market Cap (1-Jul) $738,750,080 (468th) |
Close (30-Jun) $0.55 |
Volume (30-Jun) 827,047 |
Shortsold (19-Jun) 41,649,705 (3.38%) (73rd) |
|
52w High $1.17 |
52w Low $0.335 |
P/E 6.75 |
EPS -0.43 |
OPT released this announcement to the ASX on 14 February 2023, 8:04. The announcement is marked as price sensitive, and is 2 page(s) in length and 103.86kb in size.
You can view all announcements from OPT and see how they appear on a price chart on the announcements page.
At the date of this announcement, OPT was 0.834% short sold according to ASIC data. It was ranked the 221st most shorted stock on the ASX. It is now ranked as the 73rd most shorted stock on the ASX with 3.383% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from OPT | |
|---|---|
| Change in substantial holding | 23 June 2023, 16:51 |
| Final Director's Interest Notice MS | 9 June 2023, 8:16 |
| Initial Director's Interest Notice AT | 9 June 2023, 8:15 |
| Opthea Ph2b Trial Results with OPT-302 published in Journal | 14 February 2023, 8:04 |
| Appendix 2A | 10 February 2023, 16:17 |
| Opthea to present at SVB Leerink Global Biopharma Conference | 7 February 2023, 8:15 |
| Opthea to Present at Sequire Biotechnology Conference | 31 January 2023, 7:41 |
You must be logged in to post a reply.
Opthea 